Quarterly report pursuant to Section 13 or 15(d)

Government Grant - Additional Information (Details)

v3.22.2.2
Government Grant - Additional Information (Details) - USD ($)
$ in Thousands
 9 Months Ended
Aug. 01, 2021
Sep. 30, 2022
Dec. 31, 2021
Government Grant [Line Items]      
Grant receivable   $ 145 $ 153
NIDA      
Government Grant [Line Items]      
Grant awarded $ 300 2,500  
ORCA-V1 Clinical Study Costs      
Government Grant [Line Items]      
Grant awarded   2,800  
NIDA/NIH      
Government Grant [Line Items]      
Reduction in R&D expense   700  
Grant receivable   $ 100